AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
PTC Therapeutics CEO Stuart Peltz to retire after 25 years
Biotech startups face ‘Series A cliff’ as venture capital stays cautious
Incyte hit by CRL on extended-release JAK tablets
*please scroll down for all the latest news*
